← Back to Search

Dual-Energy Computed Tomography for Brain Metastasis

N/A

Waitlist Available

Led By Jason M Johnson

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 2 years

Awards & highlights

Study Summary

This trial uses DECT to image patients with solid organ cancer that has spread to the brain. DECT may help find and diagnose tumor cells and find out how far the tumor cells have spread in the brain.

Eligible Conditions

Brain Metastasis
Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Accuracy of CT

Best diagnostic performance of computed tomography (CT) reconstruction parameters

Trial Design

1Treatment groups

Experimental Treatment

Group I: Diagnostic (DECT)Experimental Treatment1 Intervention

Within 7 days before the standard Gamma Knife MRI, patients undergo DECT scan over 6 seconds at 1.5, 5, 10, and 20 minutes after receiving the contrast agent.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Dual-Energy Computed Tomography

2018

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,967 Previous Clinical Trials

1,804,760 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,625 Total Patients Enrolled

Jason M JohnsonPrincipal InvestigatorM.D. Anderson Cancer Center

6 Previous Clinical Trials

131 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the research team currently recruiting participants for this trial?

"Per the data on clinicaltrials.gov, this trial is actively enrolling patients with a start date of August 24th 2018 and an edit to the study posted as recently as August 22nd 2022."

Answered by AI

How many participants are partaking in the experiment?

"Yes, according to the clinicaltrials.gov information, this clinical trial is presently recruiting individuals. It was posted on August 24th 2018 and has been amended as of August 22nd 2022. A total of 50 participants must be recruited from one site for it to proceed."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis

2018. "DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03685539.